Asthmatics produce lower levels of a type of immune cell protein needed to fight off infection from colds and other viruses, scientists have discovered.
The finding reported in the latest issue of the Journal of Experimental Medicine, helps to explain why asthmatics are more susceptible to respiratory virus infections -- the cause of the vast majority of acute asthma attacks in both adults and children.
The researchers, from Imperial College London and University of Southampton, found that asthmatics produce lower levels of interferon beta than healthy people.
Professor Sebastian Johnston, from Imperial College London, and St Marys Hospital, and one of the report authors, comments: "The discovery that asthmatics produce lower levels of interferons when they encounter respiratory viruses could help in the development of new treatments for asthma attacks. By giving interferons to asthma sufferers it may be possible to prevent or treat the asthma attacks, stopping sufferers from becoming hospitalised through illness."
Professor Stephen Holgate, from the University of Southampton and one of the report authors adds: "We are all very excited about this discovery because it identifies a new way of treating and preventing bad attacks of asthma associated with the common cold."
The team examined the interferon responses of cells taken from the lungs of healthy and asthmatic volunteers, measuring how effectively a cold virus (Rhinovirus) was able to replicate in them. Rhinoviruses are the major trigger of acute asthma exacerbations and asthma sufferers are more susceptible to them.
They found that the replication levels of rhinovirus-infected cells was increased 50-fold in the asthmatic group compared with the healthy control group, who were almost completely protected from infection of their lung cells. The asthmatic cells displayed very deficient interferon responses, and the researchers found that replacing the interferon protected these cells from infection, making them behave like normal cells again.
The team now believe this discovery could lead to a potential new treatment for asthma attacks by using a device similar to an asthma inhaler to top up the levels of interferons in the lungs.
Tony Stephenson | Source: EurekAlert!
Further information: www.imperial.ac.uk
More articles from Health and Medicine:
Immune system activated in schizophrenia
20.11.2009 | Karolinska Institutet
New research helps explain why bird flu has not caused a pandemic
20.11.2009 | Imperial College London
Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | Life Sciences
When good companies do bad things: Examining illegal corporate behavior
20.11.2009 | Business and Finance
UCR plant scientist's research spawns new discoveries showing how crops survive drought
20.11.2009 | Agricultural and Forestry Science
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News